Cardioprotective effect of cinnamaldehyde pretreatment on ischemia/ reperfusion injury via inhibiting NLRP3 inflammasome activation and gasdermin D mediated cardiomyocyte pyroptosis
Author:
Publisher
Elsevier BV
Subject
Toxicology,General Medicine
Reference53 articles.
1. Asiatic acid alleviates ischemic myocardial injury in mice by modulating mitophagy- and glycophagy-based energy metabolism;Qiu;Acta Pharmacol. Sin.,2021
2. Modulating mitochondrial dynamics attenuates cardiac ischemia-reperfusion injury in prediabetic rats;Maneechote;Acta Pharmacol. Sin.,2022
3. Myocardial ischemia-reperfusion injury: a neglected therapeutic target;Hausenloy;J. Clin. Invest.,2013
4. Protective effects of the soluble receptor for advanced glycation end-products on pyroptosis during myocardial ischemia-reperfusion;Liu;Oxid. Med. Cell. Longev.,2021
5. Methyl palmitate protects heart against ischemia/reperfusion-induced injury through G-protein coupled receptor 40-mediated activation of the PI3K/AKT pathway;Shen;Eur. J. Pharmacol.,2021
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Biomaterials-mediated targeted therapeutics of myocardial ischemia-reperfusion injury;Biomaterials;2023-12
2. The Shexiang Baoxin Pill Protects Myocardial Cells from Multiple Targets of MIRI through the PI3K/Akt/eNOS Signal Pathway;2023-11-14
3. Cytoprotective effects of cinnamaldehyde and adipoRon against cyclophosphamide‐induced cardio-renal toxicity in rats: Insights into oxidative stress, inflammation, and apoptosis;International Immunopharmacology;2023-11
4. Cinnamaldehyde protects donor heart from cold ischemia–reperfusion injury via the PI3K/AKT/mTOR pathway;Biomedicine & Pharmacotherapy;2023-09
5. Trans-cinnamaldehyde attenuates renal ischemia/reperfusion injury through suppressing inflammation via JNK/p38 MAPK signaling pathway;International Immunopharmacology;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3